Opens in a new tab

Dr. Cheng Bin

Chinese name: 程斌
Second-grade Professor, First-grade Chief Physician, Doctoral Supervisor . Oral Medicine & Oral Mucosal Diseases
Professor Cheng Bin is a professor and former President of the Affiliated Stomatological Hospital of Sun Yat-sen University, and Chair of the Society of Oral Mucosal Diseases of the Chinese Stomatological Association. He specialises in the diagnosis and treatment of intractable oral mucosal diseases, oral lichen planus and oral potentially malignant disorders, and researches oral carcinogenesis and mucosal ageing.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

6
Peer-reviewed papers listed on official profile
RMB 5,000,000
Guangzhou municipal research program funding (PI)
2
Corresponding-author articles in Microbiome and Redox Biology

  • The Physician

About Dr. Cheng Bin

Professor Cheng Bin is a Second-grade Professor and First-grade Chief Physician at the Affiliated Stomatological Hospital of Sun Yat-sen University, where he served as President from 2013 to 2024. A State Council Special Allowance expert, he has devoted his career to oral medicine, specialising in the diagnosis and treatment of intractable oral mucosal diseases such as oral lichen planus and oral potentially malignant disorders. His research explores the immunology of oral mucosal disease and the mechanisms of oral carcinogenesis. He has led seven national and seven provincial projects, published more than one hundred SCI papers, edited seven national textbooks, and received the Ministry of Education Science and Technology Award.
1、Former President of the Affiliated Stomatological Hospital of Sun Yat-sen University (2013-2024)
2、Chair of the Society of Oral Mucosal Diseases of the Chinese Stomatological Association
3、Vice President of the Chinese Dentists Association and Director of the Guangdong Key Laboratory of Stomatology
4、State Council Special Allowance expert and recipient of the Baosteel Outstanding Teacher award
5、First author of the Ministry of Education Science and Technology Award (Second Class) and the Guangdong Teaching Achievement Award (First Class)
6、Member of the Discipline Review Group of the State Council Academic Degrees Committee

Dr. Cheng Bin ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Oral mucosal diseases

Professor Cheng diagnoses and treats intractable oral mucosal diseases, including recurrent aphthous ulcers, oral lichen planus and burning mouth syndrome, integrating clinical examination, biopsy and individualised medical therapy to relieve symptoms and improve the quality of life of patients in routine clinical practice.

Oral potentially malignant disorders

He evaluates and manages oral leukoplakia, erythroplakia and other potentially malignant disorders, using careful clinical screening, biopsy and long-term follow-up to detect malignant transformation early, guide timely intervention and reduce the risk of oral cancer in all these high-risk patients.

Oral lichen planus

He treats oral lichen planus and other chronic inflammatory mucosal conditions with topical and systemic immunomodulatory therapy, monitoring symptoms, lesion extent and malignant potential to control flare-ups, reduce discomfort and maintain oral comfort for patients living with these persistent conditions.

More： recurrent aphthous ulcer——management; oral candidiasis——treatment; Sjogren’s syndrome——oral care; mucosal biopsy——diagnosis; oral medicine education——teaching

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Oral Potentially Malignant Disorders: Early Detection and Risk Warning
For patients with oral leukoplakia, erythroplakia or oral lichen planus, early detection of malignant transformation is critical. Professor Cheng Bin leads research on early identification and risk warning of oral potentially malignant disorders, helping clinicians monitor high-risk lesions and intervene before oral cancer develops.
2. PLIN2 and Oral Squamous Cell Carcinoma Progression
This 2025 study explores how the lipid droplet protein PLIN2 influences oral squamous cell carcinoma. For patients concerned about mouth cancer, the findings reveal molecular mechanisms driving tumour growth and suggest potential targets for the diagnosis and treatment of oral malignancy.
3. Oral Cancer Molecular Mechanisms (Review)
This review examines molecular pathways involved in the development of oral cancer. Understanding these mechanisms helps clinicians and patients recognise risk factors for oral squamous cell carcinoma and supports the development of targeted diagnostic and therapeutic strategies in oral medicine, guiding earlier detection and more precise clinical management of oral malignancy.
4. Oral Microbiome and Mucosal Disease
Using microbiome analysis, this study investigates how oral microbial communities relate to mucosal health and disease. For patients with recurrent oral ulcers, lichen planus or chronic inflammation, the work clarifies how bacteria may influence immune responses and guide future prevention or treatment.
5. Oxidative Stress in Oral Mucosal Disorders
This study focuses on redox biology in oral mucosal disease, examining how oxidative stress and cell death pathways contribute to inflammation. The findings offer insight for patients with chronic oral mucosal conditions and support antioxidant-related treatment research in oral medicine.
6. Biomaterials for Oral Mucosal Therapy
This work develops advanced biomaterials for oral applications. For patients seeking modern treatment of oral mucosal lesions, the research explores biocompatible materials that may improve drug delivery, tissue protection and healing in the oral cavity, bridging materials science and clinical oral medicine.
  • Affiliated Hospital

Where Dr. Cheng Bin practices

Guangzhou

Hospital of Stomatology Sun Yat-sen University

Chinese name: 中山大学附属口腔医院（光华口腔）
Sun Yat-sen University Hospital of Stomatology, rooted in the 1908 Guanghua tradition, is a national oral regional medical center fully covering all 8 national clinical key specialties, ranked 43rd globally in dentistry (QS 2025) and serving 700,000 annual visits with 720 dental chairs.
Since 1908
118 years of dental care
720
Dental chairs
8
National key specialties
No.43 globally
Dental chairs
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Cheng Bin?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Cheng Bin.